Bee Y. Huang

Phase I Trial of ALT-801, an Interleukin-2/T-Cell Receptor Fusion Protein Targeting p53 (aa264–272)/HLA-A*0201 Complex, in Patients with Advanced Malignancies

Mayer Fishman, John A. Thompson, Gregory Pennock et al. · Clinical Cancer Research · 2011 · 52 citations · Full text

A phase I study evaluating the pharmacokinetics, safety and tolerability of an antibody-based tissue factor antagonist in subjects with acute lung injury or acute respiratory distress syndrome

Peter E. Morris, Jay S. Steingrub, Bee Y. Huang et al. · BMC Pulmonary Medicine · 2012 · 39 citations · Full text

Single intravenous dose and steady‐state oral dose pharmacokinetics of nicardipine in healthy subjects

John G. Wagner, Teck L. Ling, Edward J. Mroszczak et al. · Biopharmaceutics & Drug Disposition · 1987 · 15 citations